COVID-19 plasma therapy has shown little benefit in patients in India, study finds

The study, published in the British Medical Journal (BMJ) involved 464 adults with moderate COVID-19 who were admitted to hospitals in India between April and July. As many as 239 adult patients received two transfusions of convalescent plasma, 24 hours apart, alongside standard care, while the control group comprising of 229 patients received standard care only.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3md53f1
via IFTTT